From: Clinical results after hybrid coronary revascularization with totally endoscopic coronary surgery
Unmatched patients | Matched patients | ||||
---|---|---|---|---|---|
HCR (N = 103) | Endo-CABG (N = 244) | p value | Endo-CABG (N = 103) | p value | |
General | |||||
30-day mortality | 0 | 5 (2.05) | 0.083 | 2 (1.94) | 0.155 |
All-cause mortality | 3 (2.91) | 35 (14.34) | 0.002 | 12 (11.65) | 0.016 |
30-day MACCE | 2 (1.94) | 11 (4.5) | 0.250 | 3 (2.91) | 0.651 |
Cardiac death | 0 | 5 (2.05) | 2 (1.94) | ||
Myocardial infarction | 0 | 2 (0.82) | 1 (0.97) | ||
Stroke | 1 (0.97) | 2 (0.82) | 0 | ||
Revascularization | 1 (0.97) | 1 (0.38) | 0 | ||
Long-term MACCE | 10 (9.71) | 34 (13.93) | 0.280 | 12 (11.65) | 0.652 |
Cardiac death | 1 (0.97) | 11 (4.51) | 4 (3.88) | ||
Myocardial infarction | 1 (0.97) | 8 (3.28) | 2 (1.94) | ||
Stroke | 1 (0.97) | 8 (3.28) | 3 (2.91) | ||
Revascularization | 7 (6.80) | 7 (2.87) | 3 (2.91) | ||
Readmissions | 24 (23.30) | 54 (22.13) | 0.898 | 27 (26.21) | 0.873 |
Arrhythmia | 6 (5.83) | 12 (4.92) | |||
AF | 3 (2.91) | 10 (4.10) | |||
VES | 1 (0.97) | 1 (0.38) | |||
Tachycardia | 2 (1.94) | 1 (0.38) | |||
Heart failure | 3 (2.91) | 9 (3.69) | |||
STEMI | 0 | 2 (0.82) | |||
NSTEMI | 2 (1.94) | 4 (1.64) | |||
Pericarditis | 1 (0.97) | 3 (0.82) | |||
Pleuritis | 0 | 4 (1.64) | |||
Syncope | 0 | 2 (0.82) | |||
Stable angina | 7 (6.80) | 12 (4.92) | |||
PCI | 6 (5.83) | 6 (2.46) | |||
No intervention | 1 (0.97) | 5 (2.46) | |||
Unstable angina | 1 (0.97) | 1 (0.38) | |||
Aspecific complaints | 3 (2.91) | 6 (2.46) | |||
Endo-CABG | |||||
Number of bypasses | 2.39 ± 0.88 | 2.96 ± 0.85 | < 0.001 | 2.88 ± 0.78 | < 0.001 |
Graft | – | – | |||
LIMA | 58 (56.31) | – | – | ||
RIMA | 3 (2.91) | – | – | ||
BIMA in situ | 9 (8.74) | 93 (38.11) | 42 (40.78) | ||
Y-graft | 33 (32.04) | 151 (61.88) | 61 (59.22) | ||
ICU LOS (h) | 70.62 ± 46.12 | 91.44 ± 101.41 | 0.009 | 82.62 ± 61.02 | 0.115 |
Ventilation time (h) | 10.43 ± 23.03 | 17.53 ± 44.79 | 0.054 | 16.38 ± 39.46 | 0.192 |
Hospital LOS (days) | 7.62 ± 3.74 | 9.46 ± 8.76 | 0.008 | 8.27 ± 3.92 | 0.222 |
Cross-clamping time (min) | 50.55 ± 25.61 | 64.00 ± 22.33 | < 0.001 | 62.32 ± 21.49 | < 0.001 |
CPB time (min) | 92.87 ± 38.81 | 110.40 ± 32.78 | < 0.001 | 109.4 ± 33.7 | 0.001 |
Perioperative bleeding (ml) | 445.10 ± 442.81 | 474.60 ± 513.66 | 0.593 | 531.1 ± 641.46 | 0.270 |
Bleeding 24 h (ml) | 541.00 ± 724.84 | 651.50 ± 680.57 | 0.191 | 645.0 ± 721.49 | 0.306 |
LVEF | |||||
> 50% | 54 (52.43) | 85 (35.12) | 36 (36.28) | ||
31–50% | 19 (18.45) | 34 (14.05) | 10 (10.78) | ||
21–30% | 1 (0.97) | 4 (1.65) | 2 (1.96) | ||
< 20% | 0 | 1 (0.41) | 1 (0.98) | ||
No TTE | 29 (28.16) | 118 (48.76) | 51 (50.00) | ||
New-onset AF | 24 (23.30) | 72 (29.51) | 0.238 | 28 (27.18) | 0.521 |
Electric cardioversion | 22 (21.36) | 36 (14.75) | 0.132 | 18 (17.48) | 0.481 |
In hospital neurological complications | 0.524 | 0.844 | |||
CVA | 1 (0.97) | 2 (0.82) | 1 (0.97) | ||
TIA | 0 | 1 (0.38) | 0 | ||
Early revision | 6 (5.83) | 21 (8.61) | 0.377 | 11 (10.78) | 0.206 |
Late revision | 2 (1.94) | 1 (0.41) | 0.159 | 1 (0.97) | 0.561 |
Graft failure | 6 (5.83) | 8 (3.28) | 0.271 | 3 (2.91) | 0.307 |
PCI | |||||
Number of stents | 1.42 ± 0.75 | – | – | – | – |
Neurological complications | |||||
CVA | 0 | – | – | – | – |
TIA | 0 | – | – | – | – |
In-stent stenosis | 3 (2.91) | – | – | – | – |
Hospital LOS | 1.96 ± 2.28 | – | – | – | – |